Improving fragile X-associated tremor/ataxia syndrome symptoms with memantine and venlafaxine

J Clin Psychopharmacol. 2010 Oct;30(5):642-4. doi: 10.1097/JCP.0b013e3181f1d10a.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Aged
  • Ataxia / drug therapy*
  • Ataxia / etiology
  • Cyclohexanols / administration & dosage*
  • Drug Therapy, Combination
  • Female
  • Follow-Up Studies
  • Fragile X Mental Retardation Protein / genetics
  • Fragile X Syndrome / complications
  • Fragile X Syndrome / drug therapy*
  • Fragile X Syndrome / genetics
  • Humans
  • Memantine / administration & dosage*
  • Tremor / drug therapy*
  • Tremor / etiology
  • Venlafaxine Hydrochloride

Substances

  • Cyclohexanols
  • FMR1 protein, human
  • Fragile X Mental Retardation Protein
  • Venlafaxine Hydrochloride
  • Memantine